GOLDENWELL BIOTECH, INC. Cash and Cash Equivalents
GOLDENWELL BIOTECH, INC. (GWLL) had Cash and Cash Equivalents of $25.72 thousand as of 2024-06-30, per its 10-Q filed 2024-08-22.
Discontinued › Balance Sheet › Assets › Assets, Current › Cash and Cash Equivalent
us-gaap:CashAndCashEquivalentsAtCarryingValue · last filed 2024-08-22
- 2024-06-30: Cash and Cash Equivalents, at Carrying Value $25.72K.
- 2023-12-31: Cash and Cash Equivalents, at Carrying Value $53.23K.
- 2022-12-31: Cash and Cash Equivalents, at Carrying Value $46.00K.
- 2022-06-30: Cash and Cash Equivalents, at Carrying Value $42.86K.
| Period end | Cash and Cash Equivalents, at Carrying Value | Cash and Cash Equivalents, at Carrying Value as first filed |
|---|---|---|
| 2024-06-30 | $25.72K 10-Q · filed 2024-08-22 | |
| 2023-12-31 | $53.23K 10-Q · filed 2024-08-22 | |
| 2022-12-31 | $46.00K 10-K · filed 2023-04-13 | |
| 2022-06-30 | $42.86K 10-Q · filed 2022-08-15 | |
| 2022-03-31 | $67.90K 10-Q · filed 2022-08-15 | |
| 2021-12-31 | $213.56K 10-K · filed 2023-04-13 | |
| 2021-09-30 | $232.93K 10-Q · filed 2022-01-03 | |
| 2021-06-30 | $245.44K 10-Q · filed 2022-08-15 | |
| 2021-03-31 | $248.57K 10-Q · filed 2022-08-15 | $268.49K 10-Q · filed 2021-08-05 |
| 2020-12-31 | $248.57K 10-K/A · filed 2023-02-06 | |
| 2020-09-30 | $250.54K 10-Q · filed 2022-01-03 | |
| 2020-06-30 | $251.42K 10-Q · filed 2021-12-02 | |
| 2020-03-31 | $251.56K 10-Q · filed 2021-08-05 | |
| 2019-12-31 | $246.59K 10-K · filed 2022-04-01 | |
| 2019-09-30 | $0.00 10-Q · filed 2021-02-23 | |
| 2018-12-31 | $0.00 10-K · filed 2021-07-23 |